Biologic and targeted therapy registry for arthritis patients
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This registry is collecting information about people with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis who are starting or needing biologic or targeted medicines. It may help researchers better understand how these treatments work in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis
- Your rheumatologist says you need to start or change to a biologic or targeted pill medicine (or a targeted injection)
- If you have ankylosing spondylitis or psoriatic arthritis, you are starting, restarting, or switching a biologic or targeted medicine
- If you have rheumatoid arthritis, your rheumatologist believes you need a biologic or targeted synthetic medicine (or a conventional medicine plan that may change)
- You agree to sign written consent to join the registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects health information from adults with certain autoimmune conditions who are currently using (or have been recommended) biologic or DMARD medicines. It may help researchers better understand these diseases and how treatments affect people over time.
This registry collects real-world information about people with rheumatoid arthritis (RA) to help doctors understand how RA medicines work and their safety. You may be able to join if you’re newly diagnosed or starting certain RA treatments and you’re willing to share consent and basic personal details.
This study is looking for people with ankylosing spondylitis, rheumatoid arthritis, or lupus to help find biomarkers that may make diagnosis easier. If you have one of these conditions and haven't tried biologic therapies, you may be able to join.
This is a patient registry that tracks people with psoriatic arthritis or spine inflammatory arthritis when they start a specific new treatment. It helps researchers learn about real-world outcomes and safety as patients receive care over time.
This study follows patients with inflammatory arthritis (rheumatoid arthritis or spondyloarthritis) to learn more about how well biologic or targeted therapies work. If you have tried standard treatments without enough relief, this may help researchers improve future care.
This study collects blood or other samples from people with rheumatology (joint/autoimmune) conditions. It looks at changes around the time you start a specific new medicine, which may help researchers understand how treatments work.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.